Global RNA-based Biopharmaceuticals Sales Market Report 2021
1 RNA-based Biopharmaceuticals Market Overview
- 1.1 RNA-based Biopharmaceuticals Product Scope
- 1.2 RNA-based Biopharmaceuticals Segment by Type
- 1.2.1 Global RNA-based Biopharmaceuticals Sales by Type (2016 & 2021 & 2027)
- 1.2.2 Therapeutics
- 1.2.3 Vaccines
- 1.3 RNA-based Biopharmaceuticals Segment by Application
- 1.3.1 Global RNA-based Biopharmaceuticals Sales Comparison by Application (2016 & 2021 & 2027)
- 1.3.2 Cancer
- 1.3.3 Diabetes
- 1.3.4 Tuberculosis
- 1.3.5 Cardiovascular Diseases
- 1.3.6 Others
- 1.4 RNA-based Biopharmaceuticals Market Estimates and Forecasts (2016-2027)
- 1.4.1 Global RNA-based Biopharmaceuticals Market Size in Value Growth Rate (2016-2027)
- 1.4.2 Global RNA-based Biopharmaceuticals Market Size in Volume Growth Rate (2016-2027)
- 1.4.3 Global RNA-based Biopharmaceuticals Price Trends (2016-2027)
2 RNA-based Biopharmaceuticals Estimates and Forecasts by Region
- 2.1 Global RNA-based Biopharmaceuticals Market Size by Region: 2016 VS 2021 VS 2027
- 2.2 Global RNA-based Biopharmaceuticals Retrospective Market Scenario by Region (2016-2021)
- 2.2.1 Global RNA-based Biopharmaceuticals Sales Market Share by Region (2016-2021)
- 2.2.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Region (2016-2021)
- 2.3 Global RNA-based Biopharmaceuticals Market Estimates and Forecasts by Region (2022-2027)
- 2.3.1 Global RNA-based Biopharmaceuticals Sales Estimates and Forecasts by Region (2022-2027)
- 2.3.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Region (2022-2027)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
- 2.4.2 Europe RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
- 2.4.3 China RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
- 2.4.4 Japan RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
- 2.4.5 Southeast Asia RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
- 2.4.6 India RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
3 Global RNA-based Biopharmaceuticals Competition Landscape by Players
- 3.1 Global Top RNA-based Biopharmaceuticals Players by Sales (2016-2021)
- 3.2 Global Top RNA-based Biopharmaceuticals Players by Revenue (2016-2021)
- 3.3 Global RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNA-based Biopharmaceuticals as of 2020)
- 3.4 Global RNA-based Biopharmaceuticals Average Price by Company (2016-2021)
- 3.5 Manufacturers RNA-based Biopharmaceuticals Manufacturing Sites, Area Served, Product Type
- 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global RNA-based Biopharmaceuticals Market Size by Type
- 4.1 Global RNA-based Biopharmaceuticals Historic Market Review by Type (2016-2021)
- 4.1.1 Global RNA-based Biopharmaceuticals Sales Market Share by Type (2016-2021)
- 4.1.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Type (2016-2021)
- 4.1.3 Global RNA-based Biopharmaceuticals Price by Type (2016-2021)
- 4.2 Global RNA-based Biopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
- 4.2.1 Global RNA-based Biopharmaceuticals Sales Forecast by Type (2022-2027)
- 4.2.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Type (2022-2027)
- 4.2.3 Global RNA-based Biopharmaceuticals Price Forecast by Type (2022-2027)
5 Global RNA-based Biopharmaceuticals Market Size by Application
- 5.1 Global RNA-based Biopharmaceuticals Historic Market Review by Application (2016-2021)
- 5.1.1 Global RNA-based Biopharmaceuticals Sales Market Share by Application (2016-2021)
- 5.1.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Application (2016-2021)
- 5.1.3 Global RNA-based Biopharmaceuticals Price by Application (2016-2021)
- 5.2 Global RNA-based Biopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
- 5.2.1 Global RNA-based Biopharmaceuticals Sales Forecast by Application (2022-2027)
- 5.2.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Application (2022-2027)
- 5.2.3 Global RNA-based Biopharmaceuticals Price Forecast by Application (2022-2027)
6 North America RNA-based Biopharmaceuticals Market Facts & Figures
- 6.1 North America RNA-based Biopharmaceuticals Sales by Company
- 6.1.1 North America RNA-based Biopharmaceuticals Sales by Company (2016-2021)
- 6.1.2 North America RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
- 6.2 North America RNA-based Biopharmaceuticals Sales Breakdown by Type
- 6.2.1 North America RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
- 6.2.2 North America RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
- 6.3 North America RNA-based Biopharmaceuticals Sales Breakdown by Application
- 6.3.1 North America RNA-based Biopharmaceuticals Sales Breakdown by Application (2016-2021)
- 6.3.2 North America RNA-based Biopharmaceuticals Sales Breakdown by Application (2022-2027)
7 Europe RNA-based Biopharmaceuticals Market Facts & Figures
- 7.1 Europe RNA-based Biopharmaceuticals Sales by Company
- 7.1.1 Europe RNA-based Biopharmaceuticals Sales by Company (2016-2021)
- 7.1.2 Europe RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
- 7.2 Europe RNA-based Biopharmaceuticals Sales Breakdown by Type
- 7.2.1 Europe RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
- 7.2.2 Europe RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
- 7.3 Europe RNA-based Biopharmaceuticals Sales Breakdown by Application
- 7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
- 7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)
8 China RNA-based Biopharmaceuticals Market Facts & Figures
- 8.1 China RNA-based Biopharmaceuticals Sales by Company
- 8.1.1 China RNA-based Biopharmaceuticals Sales by Company (2016-2021)
- 8.1.2 China RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
- 8.2 China RNA-based Biopharmaceuticals Sales Breakdown by Type
- 8.2.1 China RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
- 8.2.2 China RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
- 8.3 China RNA-based Biopharmaceuticals Sales Breakdown by Application
- 8.3.1 China 168 Sales Breakdown by Application (2016-2021)
- 8.3.2 China 168 Sales Breakdown by Application (2022-2027)
9 Japan RNA-based Biopharmaceuticals Market Facts & Figures
- 9.1 Japan RNA-based Biopharmaceuticals Sales by Company
- 9.1.1 Japan RNA-based Biopharmaceuticals Sales by Company (2016-2021)
- 9.1.2 Japan RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
- 9.2 Japan RNA-based Biopharmaceuticals Sales Breakdown by Type
- 9.2.1 Japan RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
- 9.2.2 Japan RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
- 9.3 Japan RNA-based Biopharmaceuticals Sales Breakdown by Application
- 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
- 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia RNA-based Biopharmaceuticals Market Facts & Figures
- 10.1 Southeast Asia RNA-based Biopharmaceuticals Sales by Company
- 10.1.1 Southeast Asia RNA-based Biopharmaceuticals Sales by Company (2016-2021)
- 10.1.2 Southeast Asia RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
- 10.2 Southeast Asia RNA-based Biopharmaceuticals Sales Breakdown by Type
- 10.2.1 Southeast Asia RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
- 10.2.2 Southeast Asia RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
- 10.3 Southeast Asia RNA-based Biopharmaceuticals Sales Breakdown by Application
- 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
- 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India RNA-based Biopharmaceuticals Market Facts & Figures
- 11.1 India RNA-based Biopharmaceuticals Sales by Company
- 11.1.1 India RNA-based Biopharmaceuticals Sales by Company (2016-2021)
- 11.1.2 India RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
- 11.2 India RNA-based Biopharmaceuticals Sales Breakdown by Type
- 11.2.1 India RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
- 11.2.2 India RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
- 11.3 India RNA-based Biopharmaceuticals Sales Breakdown by Application
- 11.3.1 India RNA-based Biopharmaceuticals Sales Breakdown by Application (2016-2021)
- 11.3.2 India RNA-based Biopharmaceuticals Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in RNA-based Biopharmaceuticals Business
- 12.1 Pfizer
- 12.1.1 Pfizer Corporation Information
- 12.1.2 Pfizer Business Overview
- 12.1.3 Pfizer RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.1.4 Pfizer RNA-based Biopharmaceuticals Products Offered
- 12.1.5 Pfizer Recent Development
- 12.2 Roche
- 12.2.1 Roche Corporation Information
- 12.2.2 Roche Business Overview
- 12.2.3 Roche RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.2.4 Roche RNA-based Biopharmaceuticals Products Offered
- 12.2.5 Roche Recent Development
- 12.3 Sanofi-Aventis
- 12.3.1 Sanofi-Aventis Corporation Information
- 12.3.2 Sanofi-Aventis Business Overview
- 12.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Products Offered
- 12.3.5 Sanofi-Aventis Recent Development
- 12.4 Abbott Laboratories
- 12.4.1 Abbott Laboratories Corporation Information
- 12.4.2 Abbott Laboratories Business Overview
- 12.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Products Offered
- 12.4.5 Abbott Laboratories Recent Development
- 12.5 Arrowhead Pharmaceuticals
- 12.5.1 Arrowhead Pharmaceuticals Corporation Information
- 12.5.2 Arrowhead Pharmaceuticals Business Overview
- 12.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Products Offered
- 12.5.5 Arrowhead Pharmaceuticals Recent Development
- 12.6 Benitec Biopharma
- 12.6.1 Benitec Biopharma Corporation Information
- 12.6.2 Benitec Biopharma Business Overview
- 12.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Products Offered
- 12.6.5 Benitec Biopharma Recent Development
- 12.7 Calimmune Inc
- 12.7.1 Calimmune Inc Corporation Information
- 12.7.2 Calimmune Inc Business Overview
- 12.7.3 Calimmune Inc RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.7.4 Calimmune Inc RNA-based Biopharmaceuticals Products Offered
- 12.7.5 Calimmune Inc Recent Development
- 12.8 Dicerna
- 12.8.1 Dicerna Corporation Information
- 12.8.2 Dicerna Business Overview
- 12.8.3 Dicerna RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.8.4 Dicerna RNA-based Biopharmaceuticals Products Offered
- 12.8.5 Dicerna Recent Development
- 12.9 Gradalis
- 12.9.1 Gradalis Corporation Information
- 12.9.2 Gradalis Business Overview
- 12.9.3 Gradalis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.9.4 Gradalis RNA-based Biopharmaceuticals Products Offered
- 12.9.5 Gradalis Recent Development
- 12.10 Quark
- 12.10.1 Quark Corporation Information
- 12.10.2 Quark Business Overview
- 12.10.3 Quark RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.10.4 Quark RNA-based Biopharmaceuticals Products Offered
- 12.10.5 Quark Recent Development
- 12.11 RXi
- 12.11.1 RXi Corporation Information
- 12.11.2 RXi Business Overview
- 12.11.3 RXi RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.11.4 RXi RNA-based Biopharmaceuticals Products Offered
- 12.11.5 RXi Recent Development
- 12.12 Senesco
- 12.12.1 Senesco Corporation Information
- 12.12.2 Senesco Business Overview
- 12.12.3 Senesco RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.12.4 Senesco RNA-based Biopharmaceuticals Products Offered
- 12.12.5 Senesco Recent Development
- 12.13 Silence Therapeutics
- 12.13.1 Silence Therapeutics Corporation Information
- 12.13.2 Silence Therapeutics Business Overview
- 12.13.3 Silence Therapeutics RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.13.4 Silence Therapeutics RNA-based Biopharmaceuticals Products Offered
- 12.13.5 Silence Therapeutics Recent Development
- 12.14 Silenseed
- 12.14.1 Silenseed Corporation Information
- 12.14.2 Silenseed Business Overview
- 12.14.3 Silenseed RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.14.4 Silenseed RNA-based Biopharmaceuticals Products Offered
- 12.14.5 Silenseed Recent Development
- 12.15 Tekmira
- 12.15.1 Tekmira Corporation Information
- 12.15.2 Tekmira Business Overview
- 12.15.3 Tekmira RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.15.4 Tekmira RNA-based Biopharmaceuticals Products Offered
- 12.15.5 Tekmira Recent Development
- 12.16 Alnylam Pharmaceuticals
- 12.16.1 Alnylam Pharmaceuticals Corporation Information
- 12.16.2 Alnylam Pharmaceuticals Business Overview
- 12.16.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.16.4 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Products Offered
- 12.16.5 Alnylam Pharmaceuticals Recent Development
13 RNA-based Biopharmaceuticals Manufacturing Cost Analysis
- 13.1 RNA-based Biopharmaceuticals Key Raw Materials Analysis
- 13.1.1 Key Raw Materials
- 13.1.2 Key Raw Materials Price Trend
- 13.1.3 Key Suppliers of Raw Materials
- 13.2 Proportion of Manufacturing Cost Structure
- 13.3 Manufacturing Process Analysis of RNA-based Biopharmaceuticals
- 13.4 RNA-based Biopharmaceuticals Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
- 14.1 Marketing Channel
- 14.2 RNA-based Biopharmaceuticals Distributors List
- 14.3 RNA-based Biopharmaceuticals Customers
15 Market Dynamics
- 15.1 RNA-based Biopharmaceuticals Market Trends
- 15.2 RNA-based Biopharmaceuticals Drivers
- 15.3 RNA-based Biopharmaceuticals Market Challenges
- 15.4 RNA-based Biopharmaceuticals Market Restraints
16 Research Findings and Conclusion
17 Appendix
- 17.1 Research Methodology
- 17.1.1 Methodology/Research Approach
- 17.1.2 Data Source
- 17.2 Author List
The global RNA-based Biopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global RNA-based Biopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Therapeutics
Vaccines
Segment by Application
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
The RNA-based Biopharmaceuticals market is analysed and market size information is provided by regions (countries). Segment by Application, the RNA-based Biopharmaceuticals market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals